French drugmaker Sanofi scored a win Wednesday when a Delaware federal judge invalidated patents related to rival Amgen Inc.'s cholesterol-lowering drug Repatha, upending a February jury verdict that had gone largely in Amgen's favor.
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Direct access to case information and documents.
All significant new filings across U.S. federal district courts, updated hourly on business days.
Full-text searches on all patent complaints in federal courts.